Since 2001 many major pharmaceutical companies have been restructuring their sales forces and laying off reps to reduce redundancies, improve efficiencies and cut costs. This downsizing, which likely peaked about a year ago, is mainly in response to the projected loss of sales revenue as many blockbuster drugs lose patent protection over the next three years or so. For example, products like Lipitor, Plavix and Zyprexa that currently generate more than $142 billion in sales are expected to face stiff generic competition in the very near future.
Nevertheless, while many pharma companies are restructuring their sales forces, there is a growing demand for new reps at speciality pharma, biotechnology and generic drug companies. Unlike their pharma counterparts, the new reps are more specialized and require additional training to better understand how to maximize sales of increasingly complex products in both developed and emerging life sciences markets.
One organization, National Association of Pharmaceutical Representatives (NAPRx), a trade organization that provides continuing education, certifications and career development for its members is helping to usher in the era of pharmaceutical and biotechnology sales reps. To that end, NAPRx has embarked on an aggressive advertising campaign to help to recruit and match sales representative with drug companies who are hiring. Many sales jobs are open throughout the US. Jobs are available in small cities like Littlerock, AR, Milwaukee, WI and Baton Rouge, LA as well as larger cities including Pittsburgh, PA, Los Angeles, CA,Boston, MA, Honolulu, HI and San Diego, CA. Starting salaries range from $65 to $85 K. For more information about other job openings please visit the BioJobCenter.
In a previous blog post, I suggested that a career as a sales rep may represent viable alternate career opportunities for PhD-trained scientists who have an interest in sales and aren’t averse to earning a living selling drugs to physicians and other healthcare providers. Because of the complexity of newly approved biotechnology and speciality pharma products, drug makers are beginning to understand that persons with a strong background in molecular biology, immunology and pharmacology will be required to help to sell their products to physicians, hospitals and other healthcare organizations. That said, sespite the recent reductions in R &D for new drug development, there will always be a need for drug makers to sell their products! After all, selling drugs is how these companies remain in business.
For more information about a career in pharmaceutical and biotechnology sales please visit the NAPRx website.
Until next time…
Good Luck and Good Job Hunting!!!!!!!!!!